Literature DB >> 19631699

Store-operated Ca2+ entry is sensitive to the extracellular Ca2+ concentration through plasma membrane STIM1.

Isaac Jardín1, José J López, Pedro C Redondo, Ginés M Salido, Juan A Rosado.   

Abstract

Store-operated Ca(2+) entry (SOCE) is a major mechanism for Ca(2+) influx in platelets and other cells activated by a reduction in Ca(2+) concentration in the intracellular stores. SOCE has been reported to be regulated by extracellular Ca(2+), although the underlying mechanism remains unclear. Here we have examined the involvement of plasma membrane-located STIM1 (PM-STIM1) in the regulation of SOCE by extracellular Ca(2+). Treatment of platelets with the SERCA inhibitor thapsigargin (TG) induced Mn(2+) entry, which was inhibited by extracellular Ca(2+) in a concentration-dependent manner. Incubation of platelets with a specific antibody, which recognizes the extracellular amino acid sequence 25-139 of PM-STIM1 that contains the Ca(2+)-binding domain, prevented the inactivation of Ca(2+) entry induced by extracellular Ca(2+). TG induced translocation of STIM1 to the plasma membrane (PM), an event that was found to be Ca(2+)-dependent. In addition, TG stimulated association of PM-STIM1 with Orai1, an event that was not prevented by stabilization of the membrane cytoskeleton using jasplakinolide. These findings suggest that PM-STIM1 is important for the inactivation of SOCE by extracellular Ca(2+), an event that is likely to be mediated by interaction with Orai1.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19631699     DOI: 10.1016/j.bbamcr.2009.07.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  STIM1 and STIM2 are located in the acidic Ca2+ stores and associates with Orai1 upon depletion of the acidic stores in human platelets.

Authors:  Hanene Zbidi; Isaac Jardin; Geoffrey E Woodard; Jose J Lopez; Alejandro Berna-Erro; Ginés M Salido; Juan A Rosado
Journal:  J Biol Chem       Date:  2011-02-14       Impact factor: 5.157

Review 2.  Role of oxidant scavengers in the prevention of Ca²+ homeostasis disorders.

Authors:  Carmen Galan; Isaac Jardín; Natalia Dionisio; Ginés Salido; Juan A Rosado
Journal:  Molecules       Date:  2010-10-15       Impact factor: 4.411

3.  STIM1 at the plasma membrane as a new target in progressive chronic lymphocytic leukemia.

Authors:  Marjolaine Debant; Miguel Burgos; Patrice Hemon; Paul Buscaglia; Tinhinane Fali; Sarra Melayah; Nelig Le Goux; Christophe Vandier; Marie Potier-Cartereau; Jacques-Olivier Pers; Adrian Tempescul; Christian Berthou; Cristina Bagacean; Olivier Mignen; Yves Renaudineau
Journal:  J Immunother Cancer       Date:  2019-04-23       Impact factor: 13.751

4.  Orai1α, but not Orai1β, co-localizes with TRPC1 and is required for its plasma membrane location and activation in HeLa cells.

Authors:  Jose Sanchez-Collado; Jose J Lopez; Isaac Jardin; Alejandro Berna-Erro; Pedro J Camello; Carlos Cantonero; Tarik Smani; Gines M Salido; Juan A Rosado
Journal:  Cell Mol Life Sci       Date:  2022-01-06       Impact factor: 9.261

Review 5.  Ca(2+) channels on the move.

Authors:  Colin W Taylor; David L Prole; Taufiq Rahman
Journal:  Biochemistry       Date:  2009-12-29       Impact factor: 3.162

6.  The role of plasma membrane STIM1 and Ca(2+)entry in platelet aggregation. STIM1 binds to novel proteins in human platelets.

Authors:  A Ambily; W J Kaiser; C Pierro; E V Chamberlain; Z Li; C I Jones; N Kassouf; J M Gibbins; K S Authi
Journal:  Cell Signal       Date:  2013-12-02       Impact factor: 4.315

Review 7.  STIM and Orai1 Variants in Store-Operated Calcium Entry.

Authors:  Juan A Rosado; Raquel Diez; Tarik Smani; Isaac Jardín
Journal:  Front Pharmacol       Date:  2016-01-13       Impact factor: 5.810

Review 8.  The Different Facets of Extracellular Calcium Sensors: Old and New Concepts in Calcium-Sensing Receptor Signalling and Pharmacology.

Authors:  Andrea Gerbino; Matilde Colella
Journal:  Int J Mol Sci       Date:  2018-03-27       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.